Cargando…
A Comparison of Dexmedetomidine, Moxonidine and Alpha-Methyldopa Effects on Acute, Lethal Cocaine Toxicity
BACKGROUND: The treatment of cocaine toxicity is an important subject for emergency physicians. We investigated the effects of dexmedetomidine, moxonidine and alpha-methyldopa on acute cocaine toxicity in mice. OBJECTIVES: The aim of this study was to evaluate the effects of dexmedetomidine, moxonid...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537789/ https://www.ncbi.nlm.nih.gov/pubmed/26290748 http://dx.doi.org/10.5812/ircmj.17(5)2015.18780 |
_version_ | 1782385945405816832 |
---|---|
author | Seyit, Murat Erdur, Bulent Kortunay, Selim Yuksel, Aykut Yilmaz, Atakan Ozen, Mert Uyanik, Aykut Tomruk, Onder Ergin, Ahmet |
author_facet | Seyit, Murat Erdur, Bulent Kortunay, Selim Yuksel, Aykut Yilmaz, Atakan Ozen, Mert Uyanik, Aykut Tomruk, Onder Ergin, Ahmet |
author_sort | Seyit, Murat |
collection | PubMed |
description | BACKGROUND: The treatment of cocaine toxicity is an important subject for emergency physicians. We investigated the effects of dexmedetomidine, moxonidine and alpha-methyldopa on acute cocaine toxicity in mice. OBJECTIVES: The aim of this study was to evaluate the effects of dexmedetomidine, moxonidine and alpha-methyldopa in a mouse model of acute cocaine toxicity. MATERIALS AND METHODS: We performed an experiment consisting of four groups (n = 25 each). The first group received normal saline solution, the second group received 40 µg/kg of dexmedetomidine, the third group received 0.1 mg/kg of moxonidine and the fourth group received 200 mg/kg of alpha-methyldopa, all of which were intraperitoneally administered 10 minutes before cocaine hydrochloride (105 mg/kg). All animals were observed for seizures (popcorn jumping, tonic-clonic activity, or a loss of the righting reflex) and lethality over the 30 minutes following cocaine treatment. RESULTS: The ratio of animals with convulsions was lower in all treated groups when compared to the control (P < 0.001). Furthermore, 68% (n = 17) of animals in the dexmedetomidine group, 84% (n = 21) of the alpha-methyldopa group, 92% (n = 23) of the moxonidine group and 100% (n = 25) of the control group showed evidence of seizure activity (P = 0.009). Cocaine-induced lethality was observed in 12% (n = 3) of the dexmedetomidine group, 48% (n = 12) of the alpha-methyldopa group, 52% (n = 13) of the moxonidine group, and 72% (n = 18) of the control group (P < 0.001). All treatments prolonged the time to seizure, which was longest in the dexmedetomidine group (P > 0.05). In addition, the time to lethality was also longer in the same group (P < 0.001). CONCLUSIONS: The present study provides the first experimental evidence in support of dexmedetomidine treatment for cocaine-induced seizures. Premedication with dexmedetomidine reduces seizure activity in a mouse model of acute cocaine toxicity. In addition, while dexmedetomidine may be effective, moxonidine and alpha-methyldopa did not effectively prevent cocaine-induced lethality. |
format | Online Article Text |
id | pubmed-4537789 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Kowsar |
record_format | MEDLINE/PubMed |
spelling | pubmed-45377892015-08-19 A Comparison of Dexmedetomidine, Moxonidine and Alpha-Methyldopa Effects on Acute, Lethal Cocaine Toxicity Seyit, Murat Erdur, Bulent Kortunay, Selim Yuksel, Aykut Yilmaz, Atakan Ozen, Mert Uyanik, Aykut Tomruk, Onder Ergin, Ahmet Iran Red Crescent Med J Research Article BACKGROUND: The treatment of cocaine toxicity is an important subject for emergency physicians. We investigated the effects of dexmedetomidine, moxonidine and alpha-methyldopa on acute cocaine toxicity in mice. OBJECTIVES: The aim of this study was to evaluate the effects of dexmedetomidine, moxonidine and alpha-methyldopa in a mouse model of acute cocaine toxicity. MATERIALS AND METHODS: We performed an experiment consisting of four groups (n = 25 each). The first group received normal saline solution, the second group received 40 µg/kg of dexmedetomidine, the third group received 0.1 mg/kg of moxonidine and the fourth group received 200 mg/kg of alpha-methyldopa, all of which were intraperitoneally administered 10 minutes before cocaine hydrochloride (105 mg/kg). All animals were observed for seizures (popcorn jumping, tonic-clonic activity, or a loss of the righting reflex) and lethality over the 30 minutes following cocaine treatment. RESULTS: The ratio of animals with convulsions was lower in all treated groups when compared to the control (P < 0.001). Furthermore, 68% (n = 17) of animals in the dexmedetomidine group, 84% (n = 21) of the alpha-methyldopa group, 92% (n = 23) of the moxonidine group and 100% (n = 25) of the control group showed evidence of seizure activity (P = 0.009). Cocaine-induced lethality was observed in 12% (n = 3) of the dexmedetomidine group, 48% (n = 12) of the alpha-methyldopa group, 52% (n = 13) of the moxonidine group, and 72% (n = 18) of the control group (P < 0.001). All treatments prolonged the time to seizure, which was longest in the dexmedetomidine group (P > 0.05). In addition, the time to lethality was also longer in the same group (P < 0.001). CONCLUSIONS: The present study provides the first experimental evidence in support of dexmedetomidine treatment for cocaine-induced seizures. Premedication with dexmedetomidine reduces seizure activity in a mouse model of acute cocaine toxicity. In addition, while dexmedetomidine may be effective, moxonidine and alpha-methyldopa did not effectively prevent cocaine-induced lethality. Kowsar 2015-06-01 /pmc/articles/PMC4537789/ /pubmed/26290748 http://dx.doi.org/10.5812/ircmj.17(5)2015.18780 Text en Copyright © 2015, Iranian Red Crescent Medical Journal. http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited. |
spellingShingle | Research Article Seyit, Murat Erdur, Bulent Kortunay, Selim Yuksel, Aykut Yilmaz, Atakan Ozen, Mert Uyanik, Aykut Tomruk, Onder Ergin, Ahmet A Comparison of Dexmedetomidine, Moxonidine and Alpha-Methyldopa Effects on Acute, Lethal Cocaine Toxicity |
title | A Comparison of Dexmedetomidine, Moxonidine and Alpha-Methyldopa Effects on Acute, Lethal Cocaine Toxicity |
title_full | A Comparison of Dexmedetomidine, Moxonidine and Alpha-Methyldopa Effects on Acute, Lethal Cocaine Toxicity |
title_fullStr | A Comparison of Dexmedetomidine, Moxonidine and Alpha-Methyldopa Effects on Acute, Lethal Cocaine Toxicity |
title_full_unstemmed | A Comparison of Dexmedetomidine, Moxonidine and Alpha-Methyldopa Effects on Acute, Lethal Cocaine Toxicity |
title_short | A Comparison of Dexmedetomidine, Moxonidine and Alpha-Methyldopa Effects on Acute, Lethal Cocaine Toxicity |
title_sort | comparison of dexmedetomidine, moxonidine and alpha-methyldopa effects on acute, lethal cocaine toxicity |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537789/ https://www.ncbi.nlm.nih.gov/pubmed/26290748 http://dx.doi.org/10.5812/ircmj.17(5)2015.18780 |
work_keys_str_mv | AT seyitmurat acomparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity AT erdurbulent acomparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity AT kortunayselim acomparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity AT yukselaykut acomparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity AT yilmazatakan acomparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity AT ozenmert acomparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity AT uyanikaykut acomparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity AT tomrukonder acomparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity AT erginahmet acomparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity AT seyitmurat comparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity AT erdurbulent comparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity AT kortunayselim comparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity AT yukselaykut comparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity AT yilmazatakan comparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity AT ozenmert comparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity AT uyanikaykut comparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity AT tomrukonder comparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity AT erginahmet comparisonofdexmedetomidinemoxonidineandalphamethyldopaeffectsonacutelethalcocainetoxicity |